Market research
UVP.F AusCann Group Holdings Ltd
F EUR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 12M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.57
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- AU000000AC89
- Market cap
- 12M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.57
About
About AusCann Group Holdings Ltd
AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. The company is headquartered in West Perth, Australia.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the UVP.F discussion.
5 years, 5 months ago
AusCann Group Holdings Ltd is currently in a long term downtrend where the price is trading 28.7% below its 200 day moving average.
From a valuation standpoint, the stock is 1121.8% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 16048.4.
Finally, its free cash flow grew by 20.1% to $-2M since the same quarter in the previous year.
Based on the above factors, AusCann Group Holdings Ltd gets an overall score of 1/5.